Early phase cancer clinical trials: design, ethics and future directions-Reference-Cited by-同舟云学术

Early phase cancer clinical trials: design, ethics and future directions

Published:2015-07-02 Issue:7 Volume:76 Page:409-413
ISSN:1750-8460
Container-title:British Journal of Hospital Medicine
language:en
Short-container-title:British Journal of Hospital Medicine

Author:

Coupe Nicholas¹,Gupta Avinash²,Lord Simon R³

Affiliation:

1. Clinical Research Fellow in Medical Oncology

2. Clinical Research Fellow in Medical Oncology in the Early Phase Trials Unit and the IGF Group, Department of Oncology, University of Oxford, Oxford

3. Honorary Consultant in Medical Oncology and Senior Clinical Researcher in Experimental Cancer Therapeutics in the Early Phase Trials Unit, Department of Oncology, Churchill Hospital, University of Oxford, Oxford OX3 7LE

Publisher

Mark Allen Group

Subject

General Medicine

Link

http://www.magonlinelibrary.com/doi/pdf/10.12968/hmed.2015.76.7.409

Reference23 articles.

1. EORTC guidelines for phase I trials with single agents in adults

2. PACMEL: A phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel

3. Responses and toxic deaths in Phase I clinical trials

4. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the discontinuation and nonpublication of neurooncological randomized clinical trials;Neuro-Oncology Advances;2024-01-01

2. The Challenges of Implementing Multiarmed Early Phase Oncology Clinical Trials;Novel Designs of Early Phase Trials for Cancer Therapeutics;2018